'Biomarker development' diaporamas de présentation

PSI Biomarker Special Interest Group

994 views • 57 slides

The Conquest of Cancer in the New Era of Science and Personalized Medicine

641 views • 47 slides

Biomarker development for targets with human genetic validation

Biomarker development for targets with human genetic validation. Robert M. Plenge, MD, PhD Vice President, Merck Research Laboratories (MRL) Head, Genetics & Pharmacogenomics ( GpGx ). 1. Target ID and validation. Lead optimization. Phase I-III Clinical Trials. Weak human validation.

425 views • 42 slides

Clinical Trials in Canada: Impact of Globalization

Clinical Trials in Canada: Impact of Globalization. Ghislain Boudreau, PhD Director Medical Affairs and Clinical Research Pfizer Canada Inc. R&D in Canada. Leading development pharmaceutical companies have used Canada strategically to reinforce their global development capacity.

360 views • 21 slides

Chulabhorn Graduate Institute Applied Biological Sciences : Environmental Health

Chulabhorn Graduate Institute Applied Biological Sciences : Environmental Health. Faculty members. Kavi Ratanabanangkoon * , Professor Suvit Loprasert * , Ph.D. Apinya Thiantanawat * , Ph.D. Mayuree Fuangthong * , Ph.D. Paiboon Vattanaviboon, Ph.D. Rojana Sukchawalit, Ph.D.

496 views • 15 slides

Chulabhorn Graduate Institute Applied Biological Sciences : Environmental Health

Chulabhorn Graduate Institute Applied Biological Sciences : Environmental Health. Faculty members. Kavi Ratanabanangkoon * , Professor Suvit Loprasert * , Ph.D. Apinya Thiantanawat * , Ph.D. Mayuree Fuangthong * , Ph.D. Paiboon Vattanaviboon, Ph.D. Rojana Sukchawalit, Ph.D.

172 views • 15 slides

Biomarkers: A Basic Glossary

Biomarkers: A Basic Glossary. Ramachandran S. Vasan. Circulation 2006;113:2335-2362. Desirable Features of Biomarkers of Atherosclerotic CVD. R. S. Vasan. Circulation 2006;113:2335-2362. Measures of biomarker test performance. Ramachandran S. Vasan. Circulation 2006;113:2335-2362.

222 views • 12 slides

A spin-off SME from Pharmapolis Innovative Pharmaceutical Cluster Debrecen

236 views • 11 slides